Tissue response to biphasic calcium phosphate covalently modified with either heparin or hyaluronic acid in a mouse subcutaneous implantation model.
biphasic calcium phosphate
covalent modification
ectopic osteogenesis
glycosaminoglycans
subcutaneous tissue reaction
Journal
Journal of biomedical materials research. Part A
ISSN: 1552-4965
Titre abrégé: J Biomed Mater Res A
Pays: United States
ID NLM: 101234237
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
25
10
2020
received:
06
05
2020
accepted:
28
10
2020
pubmed:
1
11
2020
medline:
13
1
2022
entrez:
31
10
2020
Statut:
ppublish
Résumé
Biphasic calcium phosphate (BCP) materials are widely employed as bone substitute materials due to their resorption/degradation properties. Inflammation after implantation of such materials represents a prerequisite for bone tissue repair and regeneration but can be also problematic if it is not only transient and if it is followed by fibrosis and scarring. Here, we modified BCP covalently with hyaluronan (HA) and heparin (Hep), glycosaminoglycans that possess anti-inflammatory properties. Beside the characterization of particle surface properties, the focus was on in vivo tissue response after subcutaneous implantation in mice. Histological analysis revealed a decrease in signs of inflammatory response to BCP when modified with either HA or Hep. Reduced vascularization after 30 days was noticed when BCP was modified with either HA or Hep with greater cellularity in all examined time points. Compared to plain BCP, expression of endothelial-related genes Flt1 and Vcam1 was higher in BCP-HA and BCP-Hep group at day 30. Expression of osteogenesis-related genes Sp7 and Bglap after 30 days was the highest in BCP group, followed by BCP-Hep, while the lowest expression was in BCP-HA group which correlates with collagen amount. Hence, coating of BCP particles with HA seems to suppress inflammatory response together with formation of new bone-like tissue, while the presence of Hep delays the onset of inflammatory response but permits osteogenesis in this subcutaneous bone-forming model. Transferring the results of this study to other coated materials intended for biomedical application may also pave the way to reduction of inflammation after their implantation.
Substances chimiques
Bone Substitutes
0
Hydroxyapatites
0
hydroxyapatite-beta tricalcium phosphate
0
Hyaluronic Acid
9004-61-9
Heparin
9005-49-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1353-1365Informations de copyright
© 2020 The Authors. Journal of Biomedical Materials Research Part A published by Wiley Periodicals LLC.
Références
Anderson JM. Biological responses to materials. Annu Rev Mat Res. 2001;31:81-110.
Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016;73(20):3861-3885.
Janicki P, Schmidmaier G. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury. 2011;42(2):S77-S81.
Kapusetti G, More N, Choppadandi M. Introduction to ideal characteristics and advanced biomedical applications of biomaterials. In: Paul S, ed. Biomedical engineering and its applications in healthcare. Singapore: Springer; 2019:171-204.
LeGeros RZ. Calcium phosphate-based osteoinductive materials. Chem Rev. 2008;108(11):4742-4753.
Jeong J, Kim JH, Shim JH, Hwang NS, Heo CY. Bioactive calcium phosphate materials and applications in bone regeneration. Biomater Res. 2019;23:4.
Lobo SE, Livingston AT. Biphasic calcium phosphate ceramics for bone regeneration and tissue engineering applications. Materials (Basel). 2010;3(2):815-826.
LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: preparation, properties and applications. J Mater Sci Mater Med. 2003;14(3):201-209.
Ebrahimi M, Botelho MG, Dorozhkin SV. Biphasic calcium phosphates bioceramics (HA/TCP): concept, physicochemical properties and the impact of standardization of study protocols in biomaterials research. Korean J Couns Psychother. 2017;71:1293-1312.
Pan J, Prabakaran S, Rajan M. In-vivo assessment of minerals substituted hydroxyapatite / poly sorbitol sebacate glutamate (PSSG) composite coating on titanium metal implant for orthopedic implantation. Biomed Pharmacother. 2019;119:109404.
Bridges AW, García AJ. Anti-inflammatory polymeric coatings for implantable biomaterials and devices. J Diabetes Sci Technol. 2008;2(6):984-994.
Severin IC, Soares A, Hantson J, et al. Glycosaminoglycan ana-logs as a novel anti-inflammatory strategy. Front Immunol. 2012;3:293.
Zhou G, Groth T. Host responses to biomaterials and anti-inflammatory design-a brief review. Macromol Biosci. 2018;18(8):e1800112.
Zhou G, Al-Khoury H, Groth T. Covalent immobilization of glycosaminoglycans to reduce the inflammatory effects of biomaterials. Int J Artif Organs. 2016;39(1):37-44.
Diez-Escudero A, Espanol M, Bonany M, Lu X, Persson C, Ginebra MP. Heparinization of Beta Tricalcium phosphate: Osteo-immunomodulatory effects. Adv Healthc Mater. 2018;7(5):1700867.
Allison DD, Grande-Allen KJ. Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng. 2006;12(8):2131-2140.
Huang L, Cheng YY, Koo PL, et al. The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures. J Biomed Mater Res A. 2003;66(4):880-884.
Kuo JW, Prestwich GD. Hyaluronic acid. In: Ducheyne P, Healy K Hutmacher D, DW Grainger & CJ Kirkpatrick, eds. Materials Of Biological Origin - Comprehensive Biomaterials. Vol 2. Amsterdam, Netherlands: Elsevier; 2011:239-259.
Köwitsch A, Yang Y, Ma N, Kuntsche J, Mäder K, Groth T. Bioactivity of immobilized hyaluronic acid derivatives regarding protein adsorption and cell adhesion. Biotechnol Appl Biochem. 2011;58(5):376-389.
Lever R, Page CP. Non-anticoagulant effects of heparin: an overview. In: Lever R, Mulloy B, Page C, eds. Heparin - a century of Progress. Handbook of experimental pharmacology. Vol 207. Berlin, Heidelberg: Springer; 2012:281-305.
Köwitsch A, Zhou G, Groth T. Medical application of glycosaminoglycans: a review. J Tissue Eng Regen Med. 2018;12(1):e23-e41.
Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res. 2008;122(6):743-752.
Hettiaratchi MH, Krishnan L, Rouse T, Chou C, McDevitt TC, Guldberg RE. Heparin-mediated delivery of bone morphogenetic protein-2 improves spatial localization of bone regeneration. Sci Adv. 2020;6(1):eaay1240.
Ahmed AG, Awartani FA, Niazy AA, Jansen JA, Alghamdi HS. A combination of biphasic calcium phosphate (Maxresorb®) and hyaluronic acid gel (Hyadent®) for repairing osseous defects in a rat model. Appl Sci. 2020;10(5):1651.
Aslan M, Simsek G, Dayi E. The effect of hyaluronic acid-supplemented bone graft in bone healing: experimental study in rabbits. J Biomater Appl. 2006;20(3):209-220.
Koca C, Komerik N, Ozmen O. Comparison of efficiency of hyaluronic acid and/or bone grafts in healing of bone defects. Niger J Clin Pract. 2019;22(6):754-762.
Rayahin JE, Buhrman JS, Zhang Y, Koh TJ, Gemeinhart RA. High and low molecular weight hyaluronic acid differentially influence macrophage activation. ACS Biomater Sci Eng. 2015;1(7):481-493.
Sieger D, Korzinskas T, Jung O, et al. The addition of high doses of hyaluronic acid to a biphasic bone substitute decreases the Proinflammatory tissue response. Int J Mol Sci. 2019;20(8):1969.
Alehosseini M, Golafshan N, Kharaziha M, Fathi M, Edris H. Hemocompatible and bioactive heparin-loaded PCL-α-TCP fibrous membranes for bone tissue engineering. Macromol Biosci. 2018;18(6):e1800020.
Quade M, Knaack S, Weber D, et al. Heparin modification of a biomimetic bone matrix modulates osteogenic and angiogenic cell response in vitro. Eur Cell Mater. 2017;33:105-120.
Najman SJ, Cvetković VJ, Najdanović JG, et al. Ectopic osteogenic capacity of freshly isolated adipose-derived stromal vascular fraction cells supported with platelet-rich plasma: a simulation of intraoperative procedure. J Craniomaxillofac Surg. 2016;44(10):1750-1760.
Najdanović JG, Cvetković VJ, Stojanović S, et al. Effects of bone tissue engineering triad components on vascularization process: comparative gene expression and histological evaluation in an ectopic bone forming model. Biotechnol Biotec Eq. 2016;30(6):1122-1131.
Cvetković VJ, Najdanović JG, Vukelić-Nikolić MĐ, Stojanović S, Najman SJ. Osteogenic potential of in vitro osteo-induced adipose-derived mesenchymal stem cells combined with platelet-rich plasma in an ectopic model. Int Orthop. 2015;39(11):2173-2180.
Najdanović JG, Cvetković VJ, Stojanović S, et al. The influence of adipose-derived stem cells induced into endothelial cells on ectopic vasculogenesis and osteogenesis. Cel Mol Bioeng. 2015;8(4):577-590.
Barbeck М, Najman S, Stojanović S, et al. Addition of blood to a phycogenic bone substitute leads to an increased in vivo vascularization. Biomed Mater. 2015;10(5):055007.
Zhou G, Niepel MS, Saretia S, Groth T. Reducing the inflammatory responses of biomaterials by surface modification with glycosaminoglycan multilayers. J Biomed Mater Res A. 2016;104(2):493-502.
Scott MA, Levi B, Askarinam A, et al. Brief review of models of ectopic bone formation. Stem Cells Dev. 2012;21(5):655-667.
Diez-Escudero A, Torreggiani E, Di Pompo G, et al. Effect of calcium phosphate heparinization on the in vitro inflammatory response and osteoclastogenesis of human blood precursor cells. J Tissue Eng Regen Med. 2019;13(7):1217-1229.
Osseni SA, Bonou SAS, Sagbo EV, et al. Synthesis of calcium phosphate bioceramics based on snail shells: towards a valorization of snail shells from Republic of Benin. Am J Chem. 2018;8(4):90-95.
Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 2007;446(7139):1030-1037.
Miron RJ, Bosshardt DD. Multinucleated Giant cells: good guys or bad guys? Tissue Eng Part B Rev. 2018;24(1):53-65.
Al-Maawi S, Orlowska A, Sader R, James Kirkpatrick C, Ghanaati S. In vivo cellular reactions to different biomaterials-physiological and pathological aspects and their consequences. Semin Immunol. 2017;29:49-61.
Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86-100.
Al-Maawi S, Rutkowski J, Sader R, Kirkpatrick CJ, Ghanaati S. The biomaterial-induced cellular reaction allows a novel classification system regardless of the biomaterials origin. J Oral Implantol. 2020;46:190-207. https://doi.org/10.1563/aaid-joi-D-19-00201. [Epub ahead of print].
AlKhoury H, Hautmann A, Erdmann F, et al. Study on the potential mechanism of anti-inflammatory activity of covalently immobilized hyaluronan and heparin. J Biomed Mater Res A. 2020;108(5):1099-1111.
Grosso A, Burger MG, Lunger A, Schaefer DJ, Banfi A, Di Maggio N. It takes two to tango: coupling of angiogenesis and osteogenesis for bone regeneration. Front Bioeng Biotechnol. 2017;5:68.
Hu K, Olsen BR. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone. 2016;91:30-38.
Byun JH, Park BW, Kim JR, Lee JH. Expression of vascular endothelial growth factor and its receptors after mandibular distraction osteogenesis. Int J Oral Maxillofac Surg. 2007;36(4):338-344.
Dirckx N, Van Hul M, Maes C. Osteoblast recruitment to sites of bone formation in skeletal development, homeostasis, and regeneration. Birth Defects Res C Embryo Today. 2013;99(3):170-191.
Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Löwik CW. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology. 2000;141(5):1667-1674.
Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal. 2011;15(6):1607-1638.
Kong DH, Kim YK, Kim MR, Jang JH, Lee S. Emerging roles of vascular cell adhesion Molecule-1 (VCAM-1) in immunological disorders and cancer. Int J Mol Sci. 2018;19(4):1057.
Ulyanova T, Scott LM, Priestley GV, et al. VCAM-1 expression in adult hematopoietic and nonhematopoietic cells is controlled by tissue-inductive signals and reflects their developmental origin. Blood. 2005;106(1):86-94.
Liu F, Akiyama Y, Tai S, et al. Changes in the expression of CD106, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bone marrow mesenchymal stem cells. J Bone Miner Metab. 2008;26(4):312-320.
Fukiage K, Aoyama T, Shibata KR, et al. Expression of vascular cell adhesion molecule-1 indicates the differentiation potential of human bone marrow stromal cells. Biochem Biophys Res Commun. 2008;365(3):406-412.